Journal of Substance Abuse Treatment

Papers
(The median citation count of Journal of Substance Abuse Treatment is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder65
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study63
Emergency department interventions for opioid use disorder: A synthesis of emerging models62
Education and careers were our way out37
Serial mediation analysis of treatment-specific processes in two contrasting alcohol treatments32
What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings31
C2: editorial board31
Can nicotine replacement therapy be personalized? A statistical learning analysis27
A randomized clinical trial evaluating the impact of counselor training and patient feedback on substance use disorder patients' sexual risk behavior26
Adapting methadone inductions to the fentanyl era26
Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform26
Drug court utilization of medications for opioid use disorder in high opioid mortality communities25
Using machine learning to examine predictors of treatment goal change among individuals seeking treatment for alcohol use disorder24
Improving geographic access to methadone clinics24
Mobile-based brief interventions targeting cannabis-impaired driving among youth: A Delphi study24
Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder24
Recidivism prevention for impaired driving: Longitudinal 5-year outcomes from Quebec's severity-based intervention assignment program23
TOC (update)23
Knowledge, attitudes, and behaviors related to the fentanyl-adulterated drug supply among people who use drugs in Oregon23
Associations between prescription and illicit stimulant and opioid use in the United States, 2015–202023
Alcohol and drug use among bartenders: An at risk population?22
C2: editorial board21
Client attitudes toward virtual treatment court18
Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?18
Consumer access to buprenorphine and methadone in certified community behavioral health centers: A secret shopper study17
Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network17
Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder16
Accessibility of substance use treatment: A qualitative study from the non-service users' perspective15
Behavioral activation for depression delivered by drug and alcohol treatment workers: A pilot randomized controlled trial15
Opioid relapse and MOUD outcomes following civil commitment for opioid use15
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder14
From there to here: A journey through substance use disorder, prison, and recovery14
Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes14
The impact of race, gender, and heroin use on opioid addiction stigma13
Traditions and Connections for Urban Native Americans (TACUNA): Utilizing community-based input to develop an opioid prevention intervention for urban American Indian/Alaska Native emerging adults13
Poking the bear: The inapplicability of the RNR principles for justice-involved women13
Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic12
Cascade of care for office-based buprenorphine treatment in Bronx community clinics11
Emergency department utilization by individuals with opioid use disorder who were recently incarcerated11
“If I had them, I would use them every time”: Perspectives on fentanyl test strip use from people who use drugs11
Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review11
National trends in buprenorphine prescribing before and during the COVID-19 pandemic10
A randomized pilot trial of a mobile phone–based brief intervention with personalized feedback and interactive text messaging to reduce driving after cannabis use and riding with a cannabis impaired d10
TOC (update)10
Factors associated with clinician treatment recommendations for patients with a new diagnosis of opioid use disorder10
The phenotype of recovery VIII: Association among delay discounting, recovery capital, and length of abstinence among individuals in recovery from substance use disorders10
TOC (update)10
Modeling the cost and impact of injectable opioid agonist therapy on overdose and overdose deaths10
Kindness, connection, and science9
Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose9
Utility of interactive voice response self-monitoring in stabilizing initial change during natural recovery attempts among persons with alcohol use disorder9
Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic8
Deaths associated with opioids, race and ethnicity, and years of potential life lost in Washington State8
Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis8
Predictors of therapeutic alliance, treatment feedback, and clinical outcomes among African American women in treatment for co-occurring PTSD and SUD8
0.22859501838684